Training and Retaining Physician Scientists in Dermatology: a UK Perspective

Objective:To determine if maintaining continuity in research topic and method from early to late career yields a greater likelihood of physician-scientists’ research-career success i.e. achieving research independence and producing impactful publications.Methods:To explore the impact of maintaining continuity in research, 108 2000-2010 neurology residency graduates from former Medical Scientist Training Programs at the highest NINDS and NIH funded institutions were identified. Through comparison of Ph.D. dissertations with post-graduate work, research continuity was deemed present if there was evidence of continuity in research topic and method. With publicly available SCOPUS, PubMed, and NIH RePORT data, the correlation that degree of continuity had with h-indices, number of grants awarded, and R01 acquisition was examined.Results:Nearly half of the graduates were classified as non-continuous (45%), less than a quarter classified as somewhat continuous (22%), and roughly a third classified as very continuous (32%). The data demonstrated that research continuity increased the ability to acquire a R01, with 83% percent of R01 and/or R21 recipients having very continuous research. Very continuous graduates also had higher median number of grants received (2 [IQR: 1-3]) and a higher median h-index (17 [IQR: 10.5-20]) compared to the somewhat continuous and non-continuous groups.Conclusions:This study highlights research continuity as an important and modifiable variable during the training period of physician-scientists and one that may improve their career success and promote greater retention within the workforce.

Download Full-text

Implementation of Federal Dependent Care Policies for Physician-Scientists at Leading US Medical Schools

JAMA Internal Medicine ◽

10.1001/jamainternmed.2019.4611 ◽

2020 ◽

Vol 180 (1) ◽

pp. 153

Author(s):

Cora H. Ormseth ◽

Christina Mangurian ◽

Reshma Jagsi ◽

Esther K. Choo ◽

Daniel H. Lowenstein ◽

...

Keyword(s):

Medical Schools ◽

Dependent Care ◽

Care Policies ◽

Physician Scientists

Download Full-text

Meeting the global need for physician-scientists: a Middle Eastern imperative

Medical Education Online ◽

10.3402/meo.v19.26138 ◽

2014 ◽

Vol 19 (1) ◽

pp. 26138 ◽

Cited By ~ 2

Author(s):

Lucman A. Anwer ◽

Ayesha N. Anwer ◽

Maryam Mahmood ◽

Ahmed Abu-Zaid ◽

Mohammad Abrar Shareef

Keyword(s):

Middle Eastern ◽

Physician Scientists

Download Full-text

Training the Next Physician Scientists

Investigative Opthalmology & Visual Science ◽

10.1167/iovs.14-14269 ◽

2014 ◽

Vol 55 (3) ◽

pp. 1856

Author(s):

David C. Beebe

Keyword(s):

Physician Scientists

Download Full-text

Gastrodia elata Blume (Tianma): Hope for Brain Aging and Dementia

Evidence-based Complementary and Alternative Medicine ◽

10.1155/2020/8870148 ◽

2020 ◽

Vol 2020 ◽

pp. 1-7

Author(s):

Klaus Heese

Keyword(s):

Brain Aging ◽

Complementary Therapy ◽

Treatment Modalities ◽

Efficacy And Safety ◽

Gastrodia Elata ◽

Herbal Preparations ◽

Gastrodia Elata Blume ◽

Novel Approach ◽

Potential Efficacy ◽

Physician Scientists

Since aging-related diseases, including dementia, represent major public health threats to our society, physician-scientists must develop innovative, interdisciplinary strategies to open new avenues for development of alternative therapies. One such novel approach may lie in traditional Chinese medicine (TCM). Gastrodia elata Blume (G. elata, tianma) is a TCM frequently used for treatment of cerebrocardiovascular diseases (CCVDs). Recent studies of G. elata-based treatment modalities, which have investigated its pharmacologically relevant activity, potential efficacy, and safety, have employed G. elata in well-characterized, aging-related disease models, with a focus on models of aging-related dementia, such as Alzheimer’s disease (AD). Here, I examine results from previous studies of G. elata, as well as related herbal preparations and pure natural products, as prophylaxis and remedies for aging-related CCVDs and dementia. Concluding, data suggest that tianma treatment may be used as a promising complementary therapy for AD.

Download Full-text